Larimar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.About LRMR
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.
CEOCarole S. Ben-Maimon
CEOCarole S. Ben-Maimon
Employees65
Employees65
HeadquartersBala Cynwyd, Pennsylvania
HeadquartersBala Cynwyd, Pennsylvania
Founded2005
Founded2005
Employees65
Employees65
LRMR Key Statistics
Market cap315.83M
Market cap315.83M
Price-Earnings ratio-1.91
Price-Earnings ratio-1.91
Dividend yield—
Dividend yield—
Average volume1.69M
Average volume1.69M
High today$3.75
High today$3.75
Low today$3.36
Low today$3.36
Open price$3.43
Open price$3.43
Volume1.01M
Volume1.01M
52 Week high$6.91
52 Week high$6.91
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
As of today, Larimar Therapeutics(LRMR) shares are valued at $3.68. The company's market cap stands at 315.83M, with a P/E ratio of -1.91.
On 2025-12-05, Larimar Therapeutics(LRMR) stock moved within a range of $3.36 to $3.75. With shares now at $3.68, the stock is trading +9.5% above its intraday low and -1.7% below the session's peak.
Trading volume for Larimar Therapeutics(LRMR) stock has reached 1.01M, versus its average volume of 1.69M.
Over the past 52 weeks, Larimar Therapeutics(LRMR) stock has traded between a high of $6.91 and a low of $1.61.
Over the past 52 weeks, Larimar Therapeutics(LRMR) stock has traded between a high of $6.91 and a low of $1.61.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LRMR. This list is generated using Robinhood data, and it’s not a recommendation.